Skip To Main Content
Mei‐Yin Polley on Muck Rack

Mei‐Yin Polley

As seen in: Wiley, Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mei‐Yin

Contact Mei‐Yin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high‐risk follicular lymphoma: CALGB 50904 (Alliance)

|
By Kristie A. Blum, Mei‐Yin Polley, Sin‐Ho Jung, Travis J. Dockter
| Wiley
Original Article Kristie A. Blum MD Corresponding Author E-mail address: kablum@emory.edu https://orcid.org/0000-0003-4229-2569 Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia Comprehensive Cancer Center, Ohio State University, Columbus, Ohio Corresponding author: Kristie A.
Open in Who Shared Issue with article?

Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high‐risk follicular lymphoma: CALGB 50904 (Alliance) - Blum - - Cancer - Wiley Online Library

|
By Kristie A. Blum, Mei‐Yin Polley, Sin‐Ho Jung, Travis J. Dockter
| Wiley Online Library Verified
Original Article Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high‐risk follicular lymphoma: CALGB 50904 (Alliance) Kristie A.
Open in Who Shared Issue with article?
See all 2 articles